Target Name: LOC101927825
NCBI ID: G101927825
Other Name(s): Uncharacterized LOC101927825, transcript variant X6 | LOC101927825 variant X6 | uncharacterized LOC101927825

LOC101927825: A protein as a drug target or biomarker

LOC101927825 (Uncharacterized LOC101927825, transcript variant X6) is a protein that is expressed in various tissues and cells of the human body. It is a member of the LOC101927825 family, which is characterized by the presence of a unique C-terminal region that is involved in protein-protein interactions.

Recent studies have identified LOC101927825 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to its unique structure and the involvement of its C-terminal region in protein-protein interactions, which can potentially regulate the activity of other proteins.

One of the key reasons for the potential drug targeting of LOC101927825 is its involvement in various signaling pathways that are involved in the development and progression of many diseases. For example, LOC101927825 has been shown to be involved in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of angiogenesis and vascular remodeling.

In addition to its involvement in signaling pathways, LOC101927825 has also been shown to play a role in the regulation of cellular processes that are important for maintaining tissue homeostasis. This includes its involvement in the regulation of cell adhesion, migration, and the formation of tissues and organs, as well as its role in the regulation of inflammation and immune responses.

The unique structure of LOC101927825, with its C-terminal region that is involved in protein-protein interactions, has led to a high degree of variability in its expression and activity. This has made it difficult to study and fully understand its role in various biological processes. However, recent studies have provided new insights into the biology of LOC101927825 and its potential as a drug target or biomarker.

In conclusion, LOC101927825 is a protein that has been identified as a potential drug target or biomarker for various diseases due to its unique structure and the involvement of its C-terminal region in protein-protein interactions. Further studies are needed to fully understand its role in various biological processes and its potential as a drug.

Protein Name: Uncharacterized LOC101927825

More Common Targets

LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971 | LOC101927995 | LOC101927998 | LOC101928004 | LOC101928007 | LOC101928008 | LOC101928012 | LOC101928014 | LOC101928047 | LOC101928053 | LOC101928080 | LOC101928093 | LOC101928120 | LOC101928135 | LOC101928143 | LOC101928152 | LOC101928163 | LOC101928180 | LOC101928195 | LOC101928201 | LOC101928219 | LOC101928230 | LOC101928251 | LOC101928268 | LOC101928269 | LOC101928272 | LOC101928273 | LOC101928274 | LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347 | LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416 | LOC101928417 | LOC101928423 | LOC101928437 | LOC101928438 | LOC101928446 | LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861